NIO's narrower Q3 loss and rising revenues highlight stronger margins and accelerating deliveries ahead of its Q4 outlook.

NIO's narrower Q3 loss and rising revenues highlight stronger margins and accelerating deliveries ahead of its Q4 outlook.

CLIR posts a narrower Q3 loss even as revenue drops and operating loss widens on higher administrative costs.

CLIR posts a narrower Q3 loss even as revenue drops and operating loss widens on higher administrative costs.

UGI posts a narrower Q4 loss and higher full-year earnings despite revenue softness and mixed performance across segments.

Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

KRO posts a wider-than-expected Q3 loss as lower TiO2 prices and weak demand hit sales, with volumes under pressure.

CENT posts a narrower Q4 loss as sales rise, gross margin expands and Garden strength offsets pressure in pet durables.

Palladyne AI incurred a narrower year-over-year loss in Q3, supported by warrant gains, as defense contracts and tech integrations position the...

Palladyne AI incurred a narrower year-over-year loss in Q3, supported by warrant gains, as defense contracts and tech integrations position the...